Treatment results for children and adolescents with acute myeloid leukemia in Middle and Eastern European countries

Treatment of Childhood Acute Myeloid Leukemia in Bulgaria

“…That is why the prognosis of patients with primary-refractory or relapsed AML still remains poor, with a 5-year overall survival (OS) rates of only about 25-35%, which turns their treatment into a challenge. [8][9][10]…”

Cure and care for children and adolescents with acute myeloid leukemia in Middle and Eastern European countries: part II

“…Recently, a valuable overview over the past and current standards, treatment results as well as challenges in the management of pediatric AML throughout several European countries including Czech Republic, Hungary, Serbia, Slovak Republic, and Poland was provided in Memo [1][2][3][4][5][6]. In this issue, further three European national pediatric hemato-oncology study groups (from Austria, Greece, and Slovenia) report their data-which were collected over a long observation period of 20 years-in a similar way [7][8][9].…”